Suppr超能文献

结肠肿瘤发生过程中单个微腺瘤自发消退和抗血管生成反应的纵向追踪

Longitudinal Tracing of Spontaneous Regression and Anti-angiogenic Response of Individual Microadenomas during Colon Tumorigenesis.

作者信息

Choi Jin Woo, Kim Pilhan, Kim Jun Ki, Kim Yi Rang, Fukumura Dai, Yun Seok Hyun

机构信息

1. Harvard Medical School and Wellman Center for Photomedicine, Massachusetts General Hospital, 40 Blossom St., Boston, MA 02114, USA ; 2. Department of Pharmacology and Dental Research Institute, School of Dentistry / Department of Smart Life-Care Convergence Graduate School, Wonkwang University, Iksan, Chonbuk 570-749, Korea ; 3. Advanced Institute of Convergence Technology, Seoul National University, Suwon Gyeonggi-do 443-270, Korea.

4. Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology, 291 Daehak-Ro, Yusong-Gu, Daejeon 305-701, Korea.

出版信息

Theranostics. 2015 Apr 1;5(7):724-32. doi: 10.7150/thno.10734. eCollection 2015.

Abstract

Angiogenesis is essential for the progression of cancer, but its involvement in the initial phase of colon tumorigenesis is not well understood. Using intravital endomicroscopy, we visualized the natural history of early pre-tumorous lesions and adenomas in the colon of conditional Apc-knockout and Apc/Kras double mutant mouse models. Early lesions emerged about 4 weeks after the onset of somatic mutations, accompanying vascular dilation when the size of lesions reached about 200 μm, but most lesions regressed spontaneously and cleared within 10 weeks after their emergence. Anti-angiogenic treatments with vascular endothelial growth factor receptor (VEGFR) antagonists reduced the size of the early lesions and the number of polyps. We found surprisingly that anti-angiogenic treatments delayed the natural clearance of transient lesions by up to several weeks in both genetic models. The results represent the previously unexpected role of early angiogenesis on the spontaneous regression of early-stage colon tumors.

摘要

血管生成对于癌症进展至关重要,但其在结肠肿瘤发生初始阶段的作用尚不清楚。我们利用活体内镜技术,在条件性Apc基因敲除和Apc/Kras双突变小鼠模型的结肠中观察了早期癌前病变和腺瘤的自然病程。早期病变在体细胞突变发生约4周后出现,当病变大小达到约200μm时伴有血管扩张,但大多数病变会自发消退,并在出现后10周内清除。使用血管内皮生长因子受体(VEGFR)拮抗剂进行抗血管生成治疗可减小早期病变的大小并减少息肉数量。我们惊奇地发现,在两种基因模型中,抗血管生成治疗均可将短暂性病变的自然清除时间延迟数周。这些结果揭示了早期血管生成在早期结肠癌自发消退过程中此前未被预料到的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02e1/4402496/63ac326d53fd/thnov05p0724g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验